Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: San Diego
State: California
Zip:
Country: United States
Genoa Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of idiopathic pulmonary fibrosis (IPF). It develops GP-101, an aerosol pirfenidone formulation for direct inhalation delivery to the lungs for the treatment of IPF. The company was founded in 2011 and is based in San Diego, California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2017 | Series A | 5 | $62M |
Andera Partners F-Prime Capital Novo Holdings RiverVest TPG Biotech Andera Partners F-Prime Capital Novo Holdings RiverVest TPG Biotech |
8/2015 | Seed Round | $2.2M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|